Department of Critical‑Care Medicine, Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China.
Department of Orthopedic Surgery, Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, P.R. China.
Mol Med Rep. 2016 Feb;13(2):1250-6. doi: 10.3892/mmr.2015.4651. Epub 2015 Dec 7.
Complement anaphylatoxins have been investigated extensively; however, the role of complement anaphylatoxin C4a in hyperoxic lung injury has yet to be investigated. To the best of our knowledge, the present study is the first to demonstrate the role of C4a in hyperoxic lung injury in vitro and in vivo. BALB/c mice were ventilated with 100% oxygen with or without C4a treatment for 36 h. The body weight and the relative lung weight of the mice were determined, along with any morphological changes in the lung. The expression levels of interleukin (IL)-1, IL-6 and tumor necrosis factor-α (TNF-α) were quantified in the lung tissue and bronchoalveolar lavage fluid (BALF) samples by enzyme-linked immunosorbent assay (ELISA) and western blot analysis. The total cell count and the number of macrophages, neutrophils and lymphocytes in the BALF were determined using cytocentrifuge slides and a hemocytometer. Histamine release from total cells in the BALF was also analyzed. The relative mRNA expression levels of CD68, F4/80, CD64, CD19 and CD3 in the murine lung tissue were assessed by reverse transcription-quantitative polymerase chain reaction. The results revealed that hyperoxia induced lung injury and morphological changes, and increased the expression levels of IL-1, IL-6 and TNF-α, histamine release, the number of inflammatory cells, and the expression levels of CD68, F4/80, CD64, CD19 and CD3. The hyperoxia-induced morphological changes and inflammatory reaction were significantly attenuated in mice treated with C4a. Treatment with C4a also attenuated the increase in the total cell count, decreased the number of macrophages in the BALF, and suppressed the elevated mRNA expression levels of CD68 and F4/80 in the lung tissue samples. Conversely, treatment with C4a did not affect the number of neutrophils or lymphocytes in the BALF or the mRNA expression of CD64, CD19 and CD3 in lung tissue. In conclusion, C4a attenuated hyperoxic lung injury via a macrophage-dependent but not a neutrophil/lymphocyte-dependent pathway.
补体过敏毒素已得到广泛研究;然而,补体过敏毒素 C4a 在高氧肺损伤中的作用尚未得到研究。据我们所知,本研究首次证明了 C4a 在高氧肺损伤中的作用在体外和体内。BALB/c 小鼠用 100%氧气通气,或用 C4a 处理,共 36 小时。测定小鼠体重和肺相对重量,以及肺的形态变化。通过酶联免疫吸附试验(ELISA)和 Western blot 分析,定量检测肺组织和支气管肺泡灌洗液(BALF)样本中白细胞介素(IL)-1、IL-6 和肿瘤坏死因子-α(TNF-α)的表达水平。使用细胞离心涂片和血球计数板测定 BALF 中的总细胞计数和巨噬细胞、中性粒细胞和淋巴细胞的数量。还分析了 BALF 中总细胞的组胺释放。通过逆转录定量聚合酶链反应评估 CD68、F4/80、CD64、CD19 和 CD3 在鼠肺组织中的相对 mRNA 表达水平。结果表明,高氧诱导肺损伤和形态变化,并增加了 IL-1、IL-6 和 TNF-α 的表达水平、组胺释放、炎症细胞数量以及 CD68、F4/80、CD64、CD19 和 CD3 的表达水平。用 C4a 处理可显著减轻高氧诱导的形态变化和炎症反应。C4a 治疗还可减轻 BALF 中总细胞计数的增加,减少 BALF 中巨噬细胞的数量,并抑制肺组织样本中 CD68 和 F4/80 的 mRNA 表达水平升高。相反,C4a 处理不影响 BALF 中的中性粒细胞或淋巴细胞数量或肺组织中 CD64、CD19 和 CD3 的 mRNA 表达。总之,C4a 通过巨噬细胞依赖而非中性粒细胞/淋巴细胞依赖的途径减轻高氧肺损伤。